SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated May 27, 2025, reports a transaction in the company's own shares. The filing discloses a share repurchase executed on May 23, 2025, through the corporate stockbroker Citigroup Global Markets Limited. The transaction was conducted on the London Stock Exchange (XLON) as part of an existing non-discretionary buyback agreement entered into on February 24, 2025.
Key Financial Metrics and Transaction Details
- Shares Purchased: 537,661 ordinary shares.
- Price Range: Lowest price paid was 1,419.00 GBp; highest price paid was 1,448.00 GBp.
- Average Price: Volume-weighted average price paid was 1,432.25 GBp.
- Treasury Holdings: Following this purchase, GSK holds 215,033,574 ordinary shares in treasury.
- Shares Outstanding: 4,100,228,473 ordinary shares are in issue (excluding treasury shares).
- Treasury Percentage: Treasury shares represent 5.2444% of ordinary shares with voting rights.
- Cumulative Buyback: Since the program inception on February 24, 2025, the company has purchased 45,963,271 ordinary shares.
Material Changes
The filing details a reduction in the number of shares outstanding available to the public and an increase in treasury stock. The total number of voting rights remains 4,100,228,473. No other material changes to the company's financial position, revenue, or operations are disclosed in this specific filing.
Guidance, Outlook, and Risks
The filing contains a standard cautionary statement regarding forward-looking statements. GSK notes that projections are subject to risks and uncertainties that may cause actual results to differ materially. Investors are directed to the "Risk Factors" section of the 2024 Annual Report on Form 20-F and the Q1 2025 Results for details on these risks. No new guidance or management commentary regarding future financial performance is provided in this document.
Investor Verification Checklist
- Verify the total cumulative buyback volume (45,963,271 shares) against previous announcements since February 24, 2025.
- Confirm the current treasury share percentage (5.2444%) against the total voting rights denominator (4,100,228,473) for disclosure threshold calculations.
- Review the Q1 2025 Results and 2024 Form 20-F for the specific risk factors referenced in the cautionary statement.
- Check the remaining authorization under the non-discretionary buyback agreement to assess future repurchase capacity.